Novo Nordisk is investing 8.5 billion Danish kroner ($1.2 billion) to establish a new production facility in Odense, Denmark—marking the first time in this century that Novo Nordisk will break ground in Denmark by establishing a new production site.    The new site will feature a finished production facility and warehouse spanning over 40,000 m2. Designed to be modular and flexible, it will accommodate multiple product types within rare disease.     “The facility will utilize advanced ...